ReviewChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery1993
Genetic factors in lissencephaly syndromes: a review.
Review in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 16 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lissencephaly is a sign of various genetic and non-genetic conditions and a constant feature in the so-called lissencephaly syndromes. Type I lissencephaly in the Miller-Dieker syndrome (MDS) and the isolated lissencephaly sequence (ILS) is differentiated from type II lissencephaly in the Walker-Warburg (hydrocephalus, agyria, retinal dysplasia with or without encephalocele, HARD +/- E) syndrome and related conditions (e.g. muscle-eye-brain syndrome). In about 90% of patients with MDS structural defects have been confirmed in the short arm of chromosome 17 (p13.3), detectable by classical cytogenetic methods, fluorescence in situ hybridisation (FISH), or molecular genetic techniques. The identification of unbalanced inversions and translocations is of particular importance because of the risk of their recurrence, while deletions and ring chromosomes are mainly sporadic. Recently, submicroscopic deletions have also been reported in ILS, providing evidence that lissencephaly in MDS and ILS is caused by deletions of the same gene(s) in 17p13.3 and that MDS may be considered to be a "contiguous gene syndrome." Syndromes featuring lissencephaly type II (HARD +/- E and related conditions) are most probably autosomal-recessively inherited. Neither the location of the genes involved nor the nature of the mutations are known at present. It is also unknown whether HARD +/- E and muscle-eye-brain syndrome are allelic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.